A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CIN3 / cervical intraepithelial neoplasia grade 3

[Related PubMed/MEDLINE]
Total Number of Papers: 160
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CIN3  (>> Co-occurring Abbreviation)
Long Form:   cervical intraepithelial neoplasia grade 3
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology. CIN2, HPV, NILM, VBA
2018 Cervical Cytology and Histology After Solid Organ Transplant: A Longitudinal Cohort Study. CI, HR-HPV, SOTs
2018 Depth of Cervical Intraepithelial Neoplasia Grade 3 in Peruvian Women: Implications for Therapeutic Depth of Necrosis. ---
2018 Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies. CIs, HPV, HRs
2018 Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women. AIS, HPV
2018 Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study. AIS
2018 Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women. CI, HR, NGS, WIHS
2018 Molecular progression to cervical precancer, epigenetic switch or sequential model? HPV, LEEP
2018 Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix. ---
10  2018 Podoplanin and SOX2 Expression in CIN 3-like Squamous Cell Carcinoma of the Cervix. PP, SCC
11  2018 Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer. ADC, HR-HPV, SCC
12  2017 A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. ---
13  2017 Anal Cancer and Anal Cancer precursors in Women with a History of HPV-Related Dysplasia and Cancer. HSIL
14  2017 Clinical management and risk reduction in women with low-grade squamous intraepithelial lesion cytology: A population-based cohort study. CI, HRs, LEEP, LSIL
15  2017 Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia? ASCUS, HR-HPV, NILM
16  2017 HPV vaccines - A review of the first decade. AIS, WHO
17  2017 Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study. HPV, HR
18  2017 Selection of women at risk for cervical cancer in an HIV-infected South African population. HR-HPV
19  2017 Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials. HPV, ICC, VE
20  2017 Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening. HPV, Pap
22  2016 Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management. HR-HPV, LBC, LSIL, NILM
23  2016 Clinical Performance of APTIMA Human Papillomavirus (HPV) 16 18/45 mRNA Genotyping Testing for the Detection of Cervical Intraepithelial Neoplasia 3 (CIN3) or Cancer in a Select Group of Chinese Women. CI, HC2, HPV, OR
24  2016 Pooled analysis of genome-wide association studies of cervical intraepithelial neoplasia 3 (CIN3) identifies a new susceptibility locus. eQTL, GWASs, HLA
25  2016 Risk Factors for Cervical Cancer and CIN3 in Jewish Women in Israel - Two Case Control Studies. ---
26  2016 SOX2 Expression in Cervical Intraepithelial Neoplasia Grade 3 (CIN3) and Superficially Invasive (Stage IA1) Squamous Carcinoma of the Cervix. CIN, SCC
27  2016 The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. CC, CI, CIS, EPIC, HR, ICC, IUD, OR
28  2015 An analysis of the outcomes of cervical cone biopsies performed in a low resource setting. ---
29  2015 Cervical cancer epidemiology in foreign women in Northern Italy: role of human papillomavirus prevalence in country of origin. HHPVC, HPV, LHPVC, SIRs
30  2015 Clinical significance of ASCUS and ASC-H cytological abnormalities: a six-year experience at a single center. ASC-H, ASCUS, CIN1, CIN2
31  2015 Clinical Significance of Atypical Squamous Cells of Undetermined Significance among Patients Undergoing Cervical Conization. ASCUS, HPV
32  2015 Cytological Analysis of Low-grade Squamous Intraepithelial Lesion with a Histodiagnosis of Cervical Intraepithelial Neoplasia 3 (Severe Dysplasia) Prospectively. LSIL, LSIL-H
33  2015 Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV. CA, HPV, Pcdh
34  2015 Prevalence and correlates of human papillomavirus genotypes among patients with cervical cancer and cervical intraepithelial neoplasia 3 in Israel. HPV
35  2015 Recent trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel. HMO, MHS
36  2015 The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. DC, ICC, SIL
37  2015 Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997-2012. AIS, EAPC, HPV, SCC
38  2014 CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer. ---
39  2014 Cervical excisional treatment of young women: a population-based study. ---
40  2014 Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients. ---
41  2014 Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women. HR-HPV
42  2014 Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality. ---
43  2014 Escharotic Treatment for ECC-positive CIN3 in Childbearing Years: A Case Report. ECC, HPV, LEEP, Pap
44  2014 Expression and localization of maspin in cervical cancer and its role in tumor progression and lymphangiogenesis. LSAB, SCC
45  2014 Gelsolin and ceruloplasmin as potential predictive biomarkers for cervical cancer by 2D-DIGE proteomics analysis. IHC
46  2014 High-risk human papillomavirus correlates with recurrence after laser ablation for treatment of patients with cervical intraepithelial neoplasia 3: a long-term follow-up retrospective study. HPV
47  2014 How best to interpret mixed human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia lesions. AIS, HPV, LCM, WTS
48  2014 HPV testing and vaccination in Europe. ASCUS, HPV
49  2014 Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme. HPV, ICC
50  2014 Microinvasive cervical squamous cell carcinoma in Slovenia during the period 2001-2007. MISCC
51  2014 Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients. 9 wk, HPV, PBMCs
52  2014 Prognostic value of p16(INK4a) as a marker of clinical evolution in patients with cervical intraepithelial neoplasia grade 3 (CIN 3) treated by cervical conization. ---
53  2014 Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. CIS, CT, EPIC, HHV-2, ICC
54  2014 Tissue genotyping of 37 in situ and invasive cervical cancer with a concomitant negative HC2 HPV DNA test. HPV, LR
55  2013 Burden of human papillomavirus infection and related diseases in Israel. HPV
56  2013 Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer. HPVs
57  2013 Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women. CIR, HPV, HSIL
58  2013 The association of the immune response genes to human papillomavirus-related cervical disease in a Brazilian population. HPV, SNPs
59  2013 The HPV test has similar sensitivity but more overdiagnosis than the Pap test--a randomised health services study on cervical cancer screening in Finland. ---
60  2013 Yield and mode of diagnosis of cervical intraepithelial neoplasia 3 or cancer among women with negative cervical cytology and positive high-risk human papillomavirus test results. ASCUS, HR-HPV
61  2012 A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalities. ASCUS, HPV, LSIL
62  2012 A review of clinical trials of human papillomavirus prophylactic vaccines. HPV, VLP
63  2012 Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3. LEEP
64  2012 Colposcopic triage methods for detecting cervical intraepithelial neoplasia grade 3 after cytopathological diagnosis of low-grade squamous intraepithelial lesion: a systematic review on diagnostic tests. ASCUS, HPV DNA, LSIL, QUADAS
65  2012 Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance. ---
66  2012 Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24. CI
67  2012 High-dose-rate intracavitary radiotherapy in the management of cervical intraepithelial neoplasia 3 and carcinoma in situ presenting with poor histologic factors after undergoing excisional procedures. CIS, HDR-ICR
68  2012 Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study. CIN2, CIN3+, HPV, ICC, PCR
69  2012 Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. CIs, HPV-16, ORs
70  2012 Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms. AUC, MeDIP-on-chip, MSP, ZNF582
71  2012 Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage Study. ALTS, LSIL, RCT
72  2012 Prediction, based on resection margins, of long-term outcome of cervical intraepithelial neoplasia 3 treated by Shimodaira-Taniguchi conization. ---
73  2012 Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers. CGIN
74  2012 Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer. HPV, SNPs
75  2012 Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma. CIN1, CIS, HR-HPV, ICC
76  2012 Tracking type specific prevalence of human papillomavirus in cervical pre-cancer: a novel sampling strategy. ---
77  2012 Utility of random cervical biopsy and endocervical curettage in a low-risk population. ECC, LEEP, SCPMG
78  2011 Associations of dietary dark-green and deep-yellow vegetables and fruits with cervical intraepithelial neoplasia: modification by smoking. ---
79  2011 Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. HPV
80  2011 Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women. CADM1, HR-HPV, qMSP
81  2011 Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study. CI, DHEAS, EPIC, ICC, ORs, SHBG
82  2011 Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. AIS, HC2, HPV, OR
83  2011 Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland. ---
84  2011 Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. ASCUS, HPV, PPV
85  2011 Selected demographic characteristics of Israeli Jewish women with high-grade cervical intraepithelial neoplasia (CIN3): a population-based study. ASR, RR
86  2010 Cervical cancer and risk for delivery of small-for-gestational age neonates. CI, MOMI, SGA, UPMC
87  2010 Common genetic variants and risk for HPV persistence and progression to cervical cancer. DMC1, DUT, HPV, IFNG, OAS3, RC, SNPs, SULF1
88  2010 Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3. ---
89  2010 Diagnostic reproducibility of cervical intraepithelial neoplasia 3 and atrophy in menopausal women on hematoxylin and eosin, Ki-67, and p16 stained slides. ---
90  2010 Human papillomavirus DNA detection in menstrual blood from patients with cervical intraepithelial neoplasia and condyloma acuminatum. ANS, CAC, HPV, MB, qRT-PCR
91  2010 Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. ASCUS, HPV, LSIL
92  2010 Impact of improved classification on the association of human papillomavirus with cervical precancer. HPV
93  2010 Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24. ASCUS, HPV, LSIL
94  2010 Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. HPV
95  2009 Accuracy of cervical specimens obtained for biomarker studies in women with CIN3. HPV, LEEP
96  2009 Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. HPV
97  2009 Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. CIs, FANCA, HPV, SNPs
98  2009 Expression of Aurora kinase A and B in normal and malignant cervical tissue: high Aurora A kinase expression in squamous cervical cancer. AC, SCC
99  2009 Human papillomavirus test after conization in predicting residual disease in subsequent hysterectomy specimens. CI, HPV, OR
100  2009 Pre-vaccination distribution of human papillomavirus (HPV) genotypes in women with cervical intraepithelial neoplasia grade 3 (CIN 3) lesions in Slovenia. HPV, PCR